Eva Serna Garcia | Physiology | Women Researcher Award

Published on by Global Academic Awards

Mrs. Eva Serna Garcia | Physiology | Women Researcher Award

Mrs. Eva Serna Garcia, Universidad de Valencia, Spain

Dr. Eva Serna Garcia is a distinguished researcher and academic at the Universitat de València’s Faculty of Medicine. With a PhD in Pharmacology 🎓 (Cum Laude) and a specialization in Medical Genetics 🧬, she has built a robust career in physiology, cardiovascular science, and molecular pharmacology. She currently serves as Profesora Titular de Universidad and has supervised numerous award-winning theses. A former Marie Curie fellow in Glasgow and Erasmus researcher in France 🌍, Eva is known for her dedication to mentoring young scientists and advancing women in research

Publication Profile

Orcid

🎓 Academic Background

Mrs. Eva Serna Garcia earned her degree in Pharmacy (Farmacia) from the Universitat de València in 2001. She pursued a PhD in Pharmacology at the same university, completing her thesis titled “Papel de las dimetilargininas en la hipertensión portal y cirrosis experimental” in 2008, graduating with the distinction Cum Laude 🏅. Her doctoral work was guided by Drs. Salvador Lluch, Paloma Lluch, and Mª Antonia Noguera 🧠. Additionally, in 2011, she completed specialized postgraduate training in Medical Genetics (Genética Médica) 🧬, further enhancing her expertise in biomedical sciences.

👩‍🏫 Teaching & Supervision Experience

Mrs. Eva Serna Garcia has an extensive background in academic mentorship, having supervised over 20 final degree, master’s, and doctoral projects at the Universitat de València 🏛️. Her guidance covers critical biomedical topics such as vascular tone modulation, aromatic hydrocarbon receptors, sex-based differences in hypertension, and cardiovascular aging 🫀. Notably, two of her supervised doctoral theses were awarded Excellent Cum Laude 🎓. She has mentored emerging scientists in exploring innovations in nutrition, pharmacogenomics, cancer biology, and neonatal health. Her dedication to academic excellence has consistently contributed to high-impact student research and scientific advancement.

🔬 Research Focus

Dr. Eva Serna García’s research centers on vascular physiology, oxidative stress, and molecular mechanisms of aging . She explores the role of dietary compounds like pomegranate and tea extracts in modulating inflammation, reactive oxygen species (ROS), and cardiovascular function. Her studies also delve into neonatal health, microbiota, sepsis, and the aryl hydrocarbon receptor (AhR) as a therapeutic target across cancer, metabolic syndrome, and neurodegeneration. By integrating nutrigenomics, epigenetics, and clinical applications, her multidisciplinary work bridges basic science and translational medicine, contributing significantly to healthy aging and disease prevention

Publication Top Notes

📘 Pomegranate Extract Modulates Oxidative Stress (2025) | [DOI: 10.3390/ijms26135957] 
📘 Sodium valproate reverses aortic hypercontractility (2025) | [DOI: 10.1016/j.ejphar.2024.177216] 
📘 Histone Deacetylase Inhibitors & Myocardial Infarction (2024) | [DOI: 10.3390/jcm13247797] 
📘 Effect of Probiotics on GI Health via AhR (2024) | [DOI: 10.3390/foods13213479] 
📘 AhR in Longevity & Healthspan (2024) | [DOI: 10.3390/ijms25189943] 
📙 FarmaSalud Mental in Pharmaceutical Context (2024) | [DOI: 10.4995/INRED2024.2024.18224] 
📙 Learning Resource Access in Medical Biology (2024) | [DOI: 10.4995/INRED2024.2024.18375] 
📘 Sodium valproate reverses endothelial dysfunction (2024) | [DOI: 10.1016/j.ejphar.2024.176475]
📘 Pomegranate Extract Prevents Oxidative Stress in Mice (2023) | [DOI: 10.3390/antiox12111991] 
📘 AhR Role in Endothelium: Systematic Review (2023) | [DOI: 10.3390/ijms241713537] 
📘 Green/Black Tea Extract & Insulin Resistance (2023) | [DOI: 10.3390/ijms24108521] 
📘 Sepsis Effects in Preterm Infants (2023) | [DOI: 10.3390/children10030602] 
📘 G6PD Overexpression & Endothelial Dysfunction (2023) | [DOI: 10.3390/ijms24043622] 
📘 Exosomal Cargo in Lung Cancer (2022) | [DOI: 10.3390/cancers14133216]

Xujie Zhou | Nephrology | Best Researcher Award

Published on by Global Academic Awards

Prof. Xujie Zhou | Nephrology | Best Researcher Award

Prof. Xujie Zhou, Peking University First Hospital, China

Xu-jie Zhou is an Associate Professor and Principal Investigator at Peking University First Hospital, specializing in nephrology and medical research. With over 20 years in clinical medicine, he has significantly contributed to the genetic, mechanistic, and therapeutic studies of kidney diseases. His research has led to the discovery of key genetic markers for IgA nephropathy and lupus, laying a foundation for precision medicine. As a respected academic and clinician, he has published over 70 high-impact papers, received prestigious awards, and actively mentors young researchers, making significant contributions to renal medicine and genetics.

Publication Profile

Google Scholar

Academic Background 🎓 

Xu-jie Zhou earned his MD and BA in English from Wuhan University of Science & Technology (2006). He further pursued a PhD in Nephrology from Peking University Institute of Nephrology (2011). His medical education and bilingual proficiency have enabled him to excel in global research collaborations. His doctoral studies laid the groundwork for groundbreaking genetic discoveries in kidney disease. With extensive postdoctoral training, he has expanded his expertise in genetic and clinical nephrology, making significant contributions to medical education, translational research, and patient care worldwide.

Professional Experience 🏥

Xu-jie Zhou has progressed through various clinical and academic roles at Peking University First Hospital since 2011. Starting as a Resident Physician (2011-2016), he advanced to Assistant Professor (2011-2017), Attending Physician (2016-2020), Associate Researcher (2017-present), Associate Chief Physician (2020-present), and Associate Professor (2021-present). Throughout his career, he has combined clinical excellence, research innovation, and mentorship. His expertise spans nephrology, genetics, and medical education, shaping the future of kidney disease treatment. His leadership in genetic nephrology and translational medicine has earned him recognition in both academic and clinical circles.

Award and Honors 🏆

Xu-jie Zhou has received numerous prestigious awards, including the National Natural Science Foundation Outstanding Youth Fund (2021), Academy of Medical Sciences Newton Advanced Fellowship (2021), Beijing Youth Top-notch Talent (2018), and Outstanding Young Physician at Peking University (2024). He has also been honored with the “Respect for Life, Honor for Doctors” Award (2023), Peking University Medical Youth Science & Technology Award (2023), and National Outstanding PhD Dissertation Nomination (2013). His contributions to medical science and education have earned widespread recognition, positioning him as a leading researcher in nephrology.

Research Focus🔬

Xu-jie Zhou specializes in genetic nephrology, with a focus on IgA nephropathy, lupus, and hereditary kidney diseases. His research includes genome-wide association studies, discovering 21 new genes for IgA nephropathy and 10 for lupus. He has pioneered studies on autophagy pathways, proposing novel therapeutic strategies. His work emphasizes precision medicine, personalized treatment, and translational research. He has published extensively in top-tier journals, influencing global nephrology research. His innovations in machine learning, single-cell analysis, and pathway genetics have transformed the understanding and treatment of complex kidney diseases.

Publication Top Notes

1️⃣ Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 🧬
📅 Year: 2021 | 📑 Cited by: 13,586

2️⃣ Exploring the Role of Autophagy-Related Gene 5 (ATG5) Yields Important Insights Into Autophagy in Autoimmune/Autoinflammatory Diseases 🔍
📅 Year: 2018 | 📑 Cited by: 273

3️⃣ Genetic association of PRDM1-ATG5 intergenic region and autophagy with systemic lupus erythematosus in a Chinese population 🧪
📅 Year: 2011 | 📑 Cited by: 271

4️⃣ High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry 🧫
📅 Year: 2016 | 📑 Cited by: 246

Conclusion

Xu-jie Zhou is a distinguished nephrologist and researcher with over 70 SCI publications in prestigious journals like Nature Genetics and Annals of the Rheumatic Diseases. His groundbreaking work in genome-wide association studies identified 21 new susceptibility genes for IgA nephropathy and 10 for lupus, significantly advancing nephrology research. He has received numerous accolades, including the National Natural Science Foundation–Outstanding Youth Foundation (2021) and the Outstanding Young Physician in Peking University (2024). As an associate editor, peer reviewer for 50+ journals, and mentor to young scholars, his contributions to research, education, and scientific leadership make him a strong candidate for the Best Researcher Award.